European Federation of Biotechnology
— advancing biotechnology through research and innovation
The EFB is a non-profit federation of biotechnology companies, academic institutions, and individual professionals. We promote research and innovation in life sciences, while providing international biotechnology conferences to ensure the dissemination of the scientific results and assist in the publication of their reports in our biotechnology Journals.
With more than 30 biotechnology conferences under its belt, the EFB portfolio of events offers a meeting point between global researchers and industry representatives.
EFB main activities:
EFB JOURNAL
New Biotechnology is the official journal of the EFB. In January 2025 Elsevier and EFB announced the merger of New Biotechnology and The Bioeconomy Journal.
EFB DIVISIONS
EFB Patron
Premium Member
EFB INSTITUTIONAL
MEMBERS
EFB NEWS
ECB2026: Abstract submission open until 19 April – final slots available
Abstract submission for the 20th European Congress on Biotechnology (ECB2026) remains open until 19 April, with final slots still available for invited talks. Participants can also apply for flash poster and poster presentations. Early registration rates are still available for a limited time.
EFB appoints new vice president following extraordinary board meeting
During an extraordinary meeting of the European Federation of Biotechnology (EFB) Executive Board held on 24 March, the board addressed key matters following the passing of Jeff Cole.